AVSD:NYE-American Century ETF Trust - Avantis Responsible International Equity ETF (USD)

ETF | Others |

Last Closing

USD 54.9246

Change

-0.18 (-0.33)%

Market Cap

USD 0.14B

Volume

2.61K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 32.43B
DTB DTB

N/A

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 10.49B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

N/A

USD 9.40B

ETFs Containing AVSD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.93% 58% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.93% 53% F 55% F
Trailing 12 Months  
Capital Gain 6.60% 52% F 58% F
Dividend Return 2.64% 48% F 39% F
Total Return 9.24% 53% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.58% 79% B- 58% F
Dividend Return 5.00% 78% C+ 51% F
Total Return 0.42% 26% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 6.84% 65% D 88% B+
Risk Adjusted Return 73.09% 96% N/A 92% A
Market Capitalization 0.14B 69% C- 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.